EIDPARRYBSEEID Parry India LtdHighNeutral
Announced Tue, 26 May · 14:26 IST

Audited Financial Results for the quarter and year ended March 31, 2026

Exceptional ItemRelated Party TransactionsContingent Liabilities IncreasedEmphasis Of MatterPat NegativeResults View source PDF

EIDPARRY · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
-6.2%1-day move
₹791.00
prior close
₹786.55
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-1.7-1.6-2.0-2.9-6.2-3.8-6.2-4.5-4.4-6.4-7.5-9.7-2.6
Up moveDown movePending
AI summary

EID Parry India Ltd reported audited financial results for FY2026. Standalone revenue from operations was Rs. 3,12,026 Lakhs, marginally down from Rs. 3,16,812 Lakhs in FY2025. The company posted a standalone loss before tax of Rs. 29,932 Lakhs for the year due to significant exceptional items totaling Rs. 82,976 Lakhs. Key exceptional items included impairment of investment in subsidiary PSRIPL (Rs. 40,060 Lakhs), provision for financial guarantee obligations (Rs. 59,132 Lakhs), and impairment of property, plant and equipment (Rs. 13,769 Lakhs), partly offset by profit on sale of Coromandel International shares (Rs. 29,764 Lakhs). The subsidiary PSRIPL ceased operations on March 31, 2026 due to sustained losses from adverse global market conditions. Consolidated results reflect net profit primarily from subsidiary Coromandel International. Statutory auditors Price Waterhouse Chartered Accountants LLP issued an unmodified (clean) opinion on both standalone and consolidated results.

Likely market impact

The standalone loss and exceptional charges indicate significant one-time write-offs related to closure of the sugar refinery subsidiary. The Rs. 59,132 Lakhs provision for financial guarantees represents a major contingent liability. While the consolidated results are profitable due to the agrichemical business, standalone shareholders face losses. The closure of PSRIPL and associated provisions may impact near-term cash flows and require monitoring.